CN Stock MarketDetailed Quotes

Chengdu huasun technology group Inc., LTD. (000790)

Watchlist
  • 3.68
  • -0.01-0.27%
Market Closed Jul 13 15:00 CST
2.30BMarket Cap-7.57P/E (TTM)

About Chengdu huasun technology group Inc., LTD. Company

Founded in 1988, the company originated as the pharmaceutical factory affiliated with Chengdu University of Traditional Chinese Medicine—the nation's first university‑run enterprise. In 1998, it underwent a shareholding reform and was listed on the Shenzhen Stock Exchange. In March 2020, Sichuan Huashen Group Co., Ltd., controlled by Yuanhong Biotechnology Co., Ltd. under the Xinghui Group, made a strategic investment to take a controlling stake. The company's core business focuses on the research, development, production, and marketing of traditional Chinese medicines, Western pharmaceuticals, and health‑related products. Its key products include Sanqi Tongshu Capsules, Biyuan Shu Oral Liquid, Huoli Su Oral Liquid, Er'gan Tuire Ning Oral Liquid, the Class I national new drug Likating (Iodine‑131 Metuximab Injection), Voriconazole Tablets, Roxithromycin Dispersible Tablets, Benzbromarone Capsules, mid‑to‑high‑end packaged drinking water, and Sanqi‑based health products. Corporate honors include: being among the first batch of technology‑innovation enterprises in Sichuan Province; a key advantageous enterprise under Sichuan Province's cross‑century development strategy; a priority advantageous enterprise in Chengdu; the only Sichuan‑based company to receive the "National Ten‑Year Achievement Award for High‑Tech Industrialization"; and awards such as the "Second Prize of the National Science and Technology Progress Award," the "National Ten‑Year Achievement Award for High‑Tech Industrialization," the "Second Prize of the International Contribution Award—Science and Technology Progress" from the World Federation of Chinese Medicine Societies, the "Second Prize of the Sichuan Provincial Science and Technology Progress Award," the "Second Prize of the Sichuan Provincial Patent Award," the designation as a "Demonstration Enterprise for the Transfer and Commercialization of Scientific and Technological Achievements in Sichuan Province," and the title of "Sichuan Provincial Industrial Quality Benchmark." Additionally, the company has been recognized as a Green Factory in Sichuan Province, included in China's Top 500 Most Valuable Brands, and ranked among the Top 100 Traditional Chinese Medicine Manufacturers in 2023.

Company Profile

Short Name-A华神科技
Symbol-A000790
Company NameChengdu huasun technology group Inc., LTD.
Listing DateMar 27, 1998
Issue Price1.00
Shares Offered17.00M share(s)
FoundedJan 27, 1988
Listed ExchangeSZ Stock Exchange
Legal Representativemingliang huang
General Managermingliangdai huang
Secretaryjun li
Accounting FirmSichuan Huaxin (Group) Certified Public Accountants (Special General Partnership)
Securities Representativeqing liu
Legal CounselBeijing Guofeng (Chengdu) Law Firm
Employees285
Phone028-66616680
Office AddressNo. 1168, Shuxin Avenue, High-tech Zone (West), Chengdu
Zip Code611731
Registered AddressRoom 101, Floor 1, Building 2, No. 1168 Shuxin Avenue, Western Zone, Chengdu High-tech Industrial Development Zone, Sichuan Province
Fax028-66616656
Emailhskj@huasungrp.com
Business License

510109000025140

Business

Development, production, and operation of high-tech products; production of traditional Chinese and Western pharmaceutical preparations and active pharmaceutical ingredients (specific business activities shall be subject to the scope approved in the drug production license and shall be limited to branch institutions conducting operations within the validity period of the license); pharmaceutical technical services and consulting, as well as commodity sales (excluding products subject to state restrictions or prohibited from circulation); property management (to be conducted with the requisite qualifications), consulting, and other services; and sales of self-developed agricultural products.

Company Executives

  • Name
  • Position
  • Salary
  • mingliang huang
  • Chairman of the Board, Director, Member of the Remuneration and Performance Review Committee, Acting President, Chairperson of the Strategic Committee, Member of the Nomination Committee
  • 647.80K
  • HUANG YANLING
  • Director
  • 75.00K
  • ping yang
  • Director, Member of the Remuneration and Performance Review Committee, Member of the Audit Committee
  • 100.00K
  • ping ouyang
  • Director, Vice President, Member of the Nomination Committee
  • 664.20K
  • duoxue wang
  • Director, Vice President, Member of the Strategy Committee
  • 658.40K
  • hai lan
  • Director, Member of the Audit Committee
  • 72.00K
  • chaoxi zhu
  • Independent Director, Chairperson of the Nomination Committee, Member of the Audit Committee, Member of the Remuneration and Performance Review Committee, Member of the Strategy Committee
  • 100.00K
  • daowei mao
  • Independent Director, Chairperson of the Remuneration and Assessment Committee, Member of the Nomination Committee, Member of the Strategy Committee, Member of the Audit Committee
  • 100.00K
  • xudong chen
  • Independent Director, Chairperson of the Audit Committee, Member of the Remuneration and Performance Review Committee, Member of the Strategy Committee, Member of the Nomination Committee
  • 100.00K
  • jun li
  • Board Secretary, Vice President, Chief Financial Officer
  • 562.50K
  • qing liu
  • Securities Affairs Representative
  • --
  • gang song
  • Vice President
  • 459.70K